Medical information Clinical review pending

Genetic Testing

Zika Virus RNA Detection Qualitative Test

Detects the presence of Zika virus RNA to diagnose active Zika virus infections, especially important for pregnant women. This qualitative test uses Real Time PCR technology for accurate results.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Serum, plasma, whole blood, cerebrospinal fluid (CSF), urine, amniotic fluid, or tissue. Confirm specific sample type requirements with the laboratory before collection.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required for this test. However, inform the laboratory about any medications you are taking and provide relevant clinical history, especially regarding travel and symptoms.

Test priceKSh 17,340

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Zika Virus RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Pregnant women with potential Zika exposure.
✓Individuals with symptoms suggestive of Zika (fever, rash, joint pain, conjunctivitis) after travel to endemic areas.
✓Individuals with recent exposure to Zika-carrying mosquitoes.
✓Confirmation of suspected Zika infection.
✓Public health surveillance.

In plain language

What this test helps you understand

Confirms an active Zika virus infection by detecting viral RNA. Essential for diagnosis, especially in pregnant women, to guide management and prevent complications like birth defects.

The Zika Virus RNA Detection Qualitative Test is a diagnostic tool used to identify an active Zika virus infection. It is particularly recommended for pregnant women, as Zika virus infection during pregnancy can cause serious birth defects. Early detection is crucial for managing potential health risks and providing appropriate care. This test uses Real Time PCR technology, known for its high sensitivity and specificity in detecting viral genetic material. The test identifies Zika virus RNA in various biological samples, confirming an active infection. Discuss your results with your healthcare provider for proper interpretation and guidance.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required for this test. However, inform the laboratory about any medications you are taking and provide relevant clinical history, especially regarding travel and symptoms.

SampleSerum, plasma, whole blood, cerebrospinal fluid (CSF), urine, amniotic fluid, or tissue. Confirm specific sample type requirements with the laboratory before collection.

MethodologyReal Time Polymerase Chain Reaction (PCR).

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects the presence of Zika virus RNA, indicating an active infection. It may not detect past infections. False negatives can occur if the sample is collected too early or too late in the infection, or if the viral load is very low. False positives are rare but possible due to cross-reactivity with similar viruses. Results should be interpreted in conjunction with clinical findings and epidemiological context.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

A positive result indicates the presence of Zika virus RNA in the sample, suggesting an active infection. You should consult your doctor immediately for further evaluation and management.

A negative result means no Zika virus RNA was detected in the sample. However, it doesn't completely rule out infection, especially if collected very early or late in the illness. Discuss the result with your doctor.

The sample collection process (e.g., blood draw) may cause mild discomfort, but the test itself is not painful.

The Real Time PCR method used is highly sensitive and specific for detecting Zika virus RNA. However, like all tests, there is a small possibility of false positive or false negative results.

Yes, anyone concerned about potential Zika exposure or experiencing symptoms should consult their doctor about testing.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp